High Mobility Group Box 3 (HMGB3) Peptid
HMGB3
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle HMGB3 Produkte
- HMGB3 (High Mobility Group Box 3 (HMGB3))
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-HMGB3 antibody (Catalog #: ARP35765_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- HMGB3 (High Mobility Group Box 3 (HMGB3))
- Hintergrund
-
The human HMG2a gene is transcribed mainly in the placenta. HMG2a encodes a protein which is part of the high mobility group (HMG) family. Members of this family are ubiquitously expressed and facilitate the formation of nucleoprotein complexes where the DNA is sharply bent.
Alias Symbols: HMG4, HMG-4, HMG2A, HMG-2a
Protein Size: 200 - Molekulargewicht
- 23 kDa
- Gen-ID
- 3149
- NCBI Accession
- NM_005342, NP_005333
- UniProt
- O15347
-
Sie sind hier:
